Журнал цитологии и гистологии

Febrile neutropenia is a frequent complication in cancer patients and affects nearly 80% with hematological malignancies and 10%-50% with solid malignancies occurring most frequently during the first chemotherapy cycle. Bacterial Bloodstream Infections (BSIs) accounts for 10% to 25% of all febrile episodes and is considered the most common among the infectious complications in febrile neutropenic patients due to the lack of adequate inflammatory response and makes sepsis a significant cause of mortality in this particular setting.